eight weeks without movement and appetite returning is almost always framed as “the dose stopped working” but I’d push back on that framing a little. there are at least three different things that could be happening and they don’t all have the same answer. one is receptor adaptation - real, documented, probably what most people mean when they say tolerance. the solution there is dose escalation or a structured break. the second is trough timing. where in your injection cycle is the appetite returning? day 5-6 before next shot, or day 2-3? because those are pharmacologically very different signals. early-cycle appetite return points to something besides trough. late-cycle is just the dose wearing off at the end of its effective window, which a bump will address. most people have never mapped this. the third is the one that’s harder to name: the difference between pharmacological suppression and actual satiety learning. the drug quiets food noise and blunts hunger signals. some people, while that’s happening, also build habits - portion size, protein timing, slower eating. some people don’t, bc the suppression does all the work and there’s nothing to build on. at plateau, when suppression lightens at trough, those two groups feel very different. and a dose bump treats both the same way even though they’re not the same problem. I’d want to know, before going up: what does the appetite feel like when it returns? physical hunger, or food noise? fwiw stomach cues, or head cues? I ask bc those aren’t the same mechanism and a higher dose addresses one more reliably than the other. I’m not saying don’t escalate - sometimes the right move is just to go up. but “I’ve been maintaining and appetite is back” is a pretty broad signal. the trough timing question is something you can actually answer with a week of notes, and it changes what you’re deciding. ymmv, this is just what I’d want to know before committing to the next step.
one thing missing from the framing: gastric emptying drift. the GI effects of GLP-1s attenuate faster than the central appetite effects, that’s been shown in the gastric emptying scintigraphy work (I read the methods on a couple of these, the half-emptying time curve flattens within weeks while CNS effects persist longer). so part of what people experience as “appetite returning” at 8 weeks is actually meal volume tolerance increasing, not hunger per se. you eat the same plate and your stomach accommodates it now. worth distinguishing from the head-vs-stomach question already raised, because the fix isn’t a dose bump, it’s portion calibration to the new emptying rate. ymmv.
the gastric emptying attenuation piece is real and it’s genuinely undermentioned in these discussions. the half-emptying time curve flattening within weeks while CNS effects persist longer is solid data, and it does explain some of what gets called “appetite returning” that isn’t hunger in any meaningful mechanistic sense. where I’d add something: “portion calibration to the new emptying rate” is doing a lot of work as a prescription. for someone without eating history, that probably translates cleanly: adjust volume, notice fullness landing at a different point, recalibrate. for someone who came into this with food noise already running loud, “your stomach accommodates more now, so eat less per sitting” and “restrict until hunger becomes manageable again” can feel functionally identical in practice even though they’re not the same thing. the behavior looks identical from the outside. what it means downstream doesn’t. I’d want that conversation to happen with someone who knows the full picture before “portion calibration” becomes the takeaway, bc the direction of that adjustment and what’s already running underneath it matter quite a bit depending on the history. the mechanistic distinction you’re drawing is useful. the rx that follows from it isn’t automatically safe for everyone who’s sitting w/ that experience.
the part I’d sit with is “the behavior looks identical from the outside.” that’s the bit that gets glossed in almost every plateau thread I read here, and you’re right that it matters. restriction-shaped eating and calibration-shaped eating produce the same plate, the same fork-down-earlier, the same lower number on the scale. the divergence shows up months later in things people don’t usually log: relationship to hunger when it returns, what the head does on a day with no plan, whether food noise comes back louder than baseline once suppression eases. by the time those signals are legible the early data is gone. where I’d add a caveat though. the way you’ve framed it, the safer path runs through a clinician who knows the history, and I agree that’s the right move where it’s available. but a lot of people in these threads don’t have a clinician who knows that history, or have one who treats GLP-1s as a weight intervention and isn’t asking about anything else (had a long chat w/ a friend last month, her GP didn’t ask a single question about prior eating patterns, just adjusted dose). so the practical question becomes what someone can do on their own to flag which group they’re in, and I’d argue the answer is mostly retrospective. did you keep notes from week 2 through week 8 on what hunger felt like and what you were eating in response? if not, the introspection at plateau is unreliable bc the drug is sitting on top of whatever’s running underneath. not a counter so much as a “the prescription is right and the access to it is the hard part.” which I suppose is true of most things in this space.
the trough-timing split is the part i’d keep, that’s the question almost nobody actually maps and it does change the call. where i’d push back a little is on which end of the cycle counts as trough on sema specifically. half-life is ~5 days so Cmax lands days 2-3, not day 7, which means day 5-6 appetite return isn’t always “the dose wearing off”, it’s sometimes just the suppression curve coming down off peak with several days of drug still on board. day 2-3 appetite return is the one i’d actually treat as the bigger signal, bc that’s the window where suppression should be hardest and something else is doing the work if hunger shows up there. the other variable i’d add to your list before escalating: dose number within the current vial. compounded sema doesn’t degrade on the pen-formulation curve most stability chatter is built on, no polysorbate 80, different profile, and a vial 8-10 doses in is genuinely not the same drug as dose 2 out of the same vial. ime that’s been the difference between “tolerance” and “this specific vial is tired” more than once, and it’s exactly the kind of soft-sounding variable that’s just a number you write down. agree hard on the physical hunger vs food noise split, that one’s load-bearing. but a food noise score on its own is noisy without a one-line context note next to it. a 4 the day after a bad sleep night reads totally different from a 4 on a normal day, and you can’t see that retrospectively without the note. the daily check-in flow i use is fast enough that i actually drop a sentence on each entry, which is the only reason the pattern is legible weeks later when i’m trying to read a stall. ymmv but i’d want dose-in-vial logged and a context note next to each food noise score before i used a week of trough data to commit to escalating, otherwise the signal carries more drift than people give it credit for.
the thing the trough-timing map misses if you’re still cycling: there’s a second clock running underneath the injection one. late luteal, ghrelin and appetite climb for reasons that have nothing to do with where you are in your shot week. so appetite coming back on day 5 one week and day 2 the next isn’t automatically noise or trough drift, it might just be that your period shifted relative to your injection day. a single week of notes won’t catch it bc a week is shorter than the cycle you’d need to read it against. I only clocked mine because I’d been logging food-noise score with cycle day next to each entry, and the monthly trend summary in CareClinic made it jump out, the appetite bumps clustered in the back half of my cycle, not at trough. before I overlaid those two I’d have filed it under dose fatigue and probably asked to go up. where my window doesn’t transfer: week 18, sema, still cycling. if you’re peri or post or on continuous HRT this layer mostly collapses and the trough read is cleaner. trial pops don’t stratify well on this either, which is part of why it’s underdescribed. not arguing against escalating. just that “appetite is back” gets read against the injection clock when for a lot of us there are two clocks. anyone marked cycle phase against trough and watched them drift independently?
the variable nobody’s named here is the vial itself. if you’re drawing from a multi-dose vial and the appetite creep tracks the age of the vial rather than the injection cycle, that’s a third clock entirely, and it looks exactly like tolerance. aggregation/deamidation over a 4-week vial life can shave potency week by week, and an 8 mg/dL drift in your hunger cues across the back half of a vial is the kind of slow signal that gets read as “the dose stopped working” when it’s really “this vial isn’t what it was on day 1.” compounded vials especially, where you don’t have the branded buffer doing the stabilizing. cheap thing to rule out: note which vial and how old when the appetite shows up. fwiw the monthly trend view in the app I log in made that pattern obvious for me, the dips lined up with new vials more than with dose changes.